BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui D, Li W, Jiang D, Wu J, Xie J, Wu Y. Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:754709. [PMID: 34660653 DOI: 10.3389/fmed.2021.754709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hou G, Xu W, Ding D, Tian T, Liu G, Yang Y, Liu H, Zhou W. Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma. J Gastroenterol Hepatol 2022;37:2321-30. [PMID: 36208127 DOI: 10.1111/jgh.16024] [Reference Citation Analysis]
2 Armakolas A, Dimopoulou V, Nezos A, Stamatakis G, Samiotaki M, Panayotou G, Tampaki M, Stathaki M, Dourakis S, Koskinas J. Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma. Curr Issues Mol Biol 2022;44:4714-34. [PMID: 36286037 DOI: 10.3390/cimb44100322] [Reference Citation Analysis]
3 Li Z, He Q, Peng J, Yan Y, Fu C, Xu Y. Identification of Downregulated Exosome-Associated Gene ENPP1 as a Novel Lipid Metabolism and Immune-Associated Biomarker for Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/4834791] [Reference Citation Analysis]
4 Huang S, Chen S, Zhang D, Gao J, Liu L. Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma. Front Genet 2022;13:fgene-2022-1008602. [DOI: 10.3389/fgene.2022.1008602] [Reference Citation Analysis]
5 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]